Market cap
$3,804 Mln
Revenue (TTM)
$1,543 Mln
P/E Ratio
27.5
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
44.41
-
EV/EBITDA
11.5
-
Debt to Equity
0.5
-
Book Value
$--
-
EPS
$2.3
-
Face value
--
-
Shares outstanding
59,654,855
10 Years Aggregate
CFO
$975.40 Mln
EBITDA
$893.07 Mln
Net Profit
$349.43 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| -27.5 | -5.8 | -22.3 | -33.8 | -8.9 | 0.6 | 12.9 |
|
BSE Sensex
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| -8.9 | 27.1 | 7.6 | 13.4 | 12.2 | 77.8 | -44.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
|
63.9 | 3,804.2 | 1,542.8 | 139.3 | 12.1 | 8.8 | 27.5 | 2.2 |
| 7.9 | 5,216.3 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 267.4 | 7,156.9 | 2,589.9 | 168.8 | 21.4 | 2.5 | 44.4 | 1.0 | |
| 45.8 | 6,483.3 | 3,458.5 | -11.6 | 2.6 | -0.5 | -- | 2.7 | |
| 23.7 | 3,750.9 | 2,808.1 | 67.7 | 6.8 | 2.2 | 56.2 | 1.2 | |
| 127.6 | 8,216.9 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 12.2 | |
| 94.1 | 6,047.7 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.2 | 5.0 | |
| 178.6 | 9,363.6 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.3 | 11.8 | |
| 328.4 | 12,843.7 | 1,454.3 | 171.1 | 11.1 | 12.1 | 75.2 | 8.7 | |
| 114.6 | 6,121.4 | 763.3 | 51.4 | 11.7 | 2.5 | 119.3 | 2.8 |
Shareholding Pattern
View DetailsAbout Merit Medical Systems (MMSI)
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and... internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095 Read more
-
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
-
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
-
Headquarters
South Jordan, UT
-
Website
FAQs for Merit Medical Systems (MMSI)
What is the current share price of Merit Medical Systems Inc (MMSI) Today?
The share price of Merit Medical Systems Inc (MMSI) is $63.90 (NASDAQ) as of 22-May-2026 13:35 EDT. Merit Medical Systems Inc (MMSI) has given a return of -8.93% in the last 3 years.
What is the current PB & PE ratio of Merit Medical Systems Inc (MMSI)?
The P/E ratio of Merit Medical Systems Inc (MMSI) is 27.49 times as on 20-May-2026, a 38 discount to its peers’ median range of 44.41 times.
The P/B ratio of Merit Medical Systems Inc (MMSI) is 2.25 times as on 20-May-2026, a 22 discount to its peers’ median range of 2.90 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
41.18
|
3.34
|
|
2024
|
48.71
|
4.25
|
|
2023
|
46.97
|
3.69
|
|
2022
|
54.93
|
3.58
|
|
2021
|
74.09
|
3.45
|
What is the 52 Week High and Low of Merit Medical Systems Inc (MMSI)?
The 52-week high and low of Merit Medical Systems Inc (MMSI) are Rs 97.18 and Rs 59.74 as of 22-May-2026.
What is the market cap of Merit Medical Systems Inc (MMSI)?
Merit Medical Systems Inc (MMSI) has a market capitalisation of $ 3,804 Mln as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Merit Medical Systems Inc (MMSI)?
Before investing in Merit Medical Systems Inc (MMSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.